INDOCID

This brand name is authorized in Australia, Austria, Brazil, Estonia, France, Hong Kong SAR China, Mexico, UK.

Active ingredients

The drug INDOCID contains one active pharmaceutical ingredient (API):

1
UNII 0IMX38M2GG - INDOMETHACIN SODIUM
 

Indometacin has anti-inflammatory, antipyretic, and analgesic effects, it is an inhibitor of prostaglandin synthetase.

 
Read more about Indometacin

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 INDOCID Suppositories MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 INDOCID Capsules MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
C01EB03 Indometacin C Cardiovascular system → C01 Cardiac therapy → C01E Other cardiac preparations → C01EB Other cardiac preparations
Discover more medicines within C01EB03
M01AB01 Indometacin M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AB Acetic acid derivatives and related substances
Discover more medicines within M01AB01
M02AA23 Indometacin M Musculo-skeletal system → M02 Topical products for joint and muscular pain → M02A Topical products for joint and muscular pain → M02AA Antiinflammatory preparations, non-steroids for topical use
Discover more medicines within M02AA23
S01BC01 Indometacin S Sensory organs → S01 Ophthalmologicals → S01B Antiinflammatory agents → S01BC Antiinflammatory agents, non-steroids
Discover more medicines within S01BC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
AU Pharmaceutical Benefits Scheme 2454E, 2757D, 5126T, 5128X, 5377B
BR Câmara de Regulação do Mercado de Medicamentos 505609501111317, 505609502118315
EE Ravimiamet 1205626, 1274532, 1870084
FR Base de données publique des médicaments 66664685, 68142440
GB Medicines & Healthcare Products Regulatory Agency 18784
HK Department of Health Drug Office 01934
MX Comisión Federal para la Protección contra Riesgos Sanitarios 61533, 64785

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.